The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Abedini B.

School of pharmacy — Shiraz university of medical sciences;
Pharmaceutical Sciences Research Center — Shiraz University of Medical Sciences

Maggot therapy for wound management and its mechanisms: a review of published literature

Authors:

Abedini B.

More about the authors

Journal: Medical Technologies. Assessment and Choice. 2024;46(2): 22‑27

DOI: 10.17116/medtech20244602122

Read: 898 times

Download PDF (RU)
Contact the author
Table of contents

MAGGOT THERAPY FOR WOUND MANAGEMENT AND ITS MECHANISMS: A REVIEW OF PUBLISHED LITERATURE
MAGGOT THERAPY FOR WOUND MANAGEMENT AND ITS MECHANISMS: A REVIEW OF PUBLISHED LITERATURE

To cite this article:

Abedini B. Maggot therapy for wound management and its mechanisms: a review of published literature. Medical Technologies. Assessment and Choice. 2024;46(2):22‑27. (In Russ.)
https://doi.org/10.17116/medtech20244602122

Подписка 2026 Медицинские технологии. Оценка и выбор (Medical Technologies. Assessment and Choice)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Problems associated with wound healing are currently a considerable issue. Conventional methods for wound treatment have several disadvantages. For example, diabetic ulcer problems cause many failures for conventional wound treatment. Maggot therapy is an alternative for those conventional methods. It has shown promising results in several studies and has notable advantages in comparison with conventional methods for wound treatment. However, despite its advantages, maggot therapy is underutilized in healthcare systems. A well-known species used for maggot therapy is Lucilia sericata showing safety and effectiveness for treatment of wounds. In this study, different aspects of maggot therapy, for instance research results related to maggot therapy, providing favorable situation for maggots, influential factors in maggot therapy, and wound healing mechanisms of maggot therapy were reviewed. Altogether maggot therapy can be applied as a favorable alternative method for wound healing.

Keywords:

larval therapy
Lucilia sericata
maggot debridement therapy
chronic wound
diabetic foot

Authors:

Abedini B.

School of pharmacy — Shiraz university of medical sciences;
Pharmaceutical Sciences Research Center — Shiraz University of Medical Sciences

Received:

11.08.2023

Accepted:

07.05.2024

Close metadata

References:

  1. Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair and Regeneration. 2003;11:S1-S28.  https://doi.org/10.1046/j.1524-475x.11.s2.1.x
  2. Nigam Y, Bexfield A, Thomas S, Ratcliffe NA. Maggot therapy: the science and implication for CAM Part I—history and bacterial resistance. Evidence-based Complementary and Alternative Medicine. 2006;3(2):223-227.  https://doi.org/10.1093/ecam/nel021
  3. Gasz N, Geary M, Doggett S, Harvey M. Bacterial association observations in Lucilia sericata and Lucilia cuprina organs through 16S rRNA gene sequencing. Applied Microbiology and Biotechnology. 2021;105(3):1091-1106. https://doi.org/10.1007/s00253-020-11026-8
  4. Vinogradova E. The Blowfly Calliphora vicina as a Model Object for Physiological and Ecological Studies. Trudy Zool Inst Akad Nauk SSSR. 1984;118:1-272. 
  5. Kilinc O, Arkan H, Akbaş F, Polat E, Tuncdemir M, Onaran I, et al. The effects of Lucilia sericata larval secretions on the expressions of MicroRNAs that are suggested to be related with wound healing in experimental diabetic rat wound model. Bezmialem Science. 2020;8(1):8-13.  https://doi.org/10.14235/bas.galenos.2018.2370
  6. Tantawi TI, Gohar YM, William SG, Kotb MM, Abou Zeid NA. Clinical and microbiological efficacy of medicinal maggots in the treatment of pressure ulcers in Egypt. Journal of Bioscience and Applied Research. 2017;3(4):152-177.  https://doi.org/10.21608/JBAAR.2017.126133
  7. Abela G. Benefits of maggot debridement therapy on leg ulcers: a literature review. British Journal of Community Nursing. 2017;22 (Suppl 6):S14-S19.  https://doi.org/10.12968/bjcn.2017.22.Sup6.S14
  8. Beasley W, Hirst G. Making a meal of MRSA—the role of biosurgery in hospital-acquired infection. Journal of Hospital Infection. 2004;56(1):6-9.  https://doi.org/10.1016/j.jhin.2003.09.002
  9. Malekian A, Djavid GE, Akbarzadeh K, Soltandallal M, Rassi Y, Rafinejad J, et al. Efficacy of maggot therapy on Staphylococcus aureus and Pseudomonas aeruginosa in diabetic foot ulcers: a randomized controlled trial. Journal of Wound Ostomy & Continence Nursing. 2019;46(1):25-29.  https://doi.org/10.1097/WON.0000000000000496
  10. Pöppel AK, Vogel H, Wiesner J, Vilcinskas A. Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria. Antimicrob Agents Chemother. 2015;59(5):2508-2514. https://doi.org/10.1128/AAC.05180-14
  11. Linger RJ, Belikoff EJ, Yan Y, Li F, Wantuch HA, Fitzsimons HL, et al. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor. BMC Biotechnology. 2016;16(1):1-12.  https://doi.org/10.1186/s12896-016-0263-z
  12. Concha C, Belikoff EJ, Carey B-l, Li F, Schiemann AH, Scott MJ. Efficient germ-line transformation of the economically important pest species Lucilia cuprina and Lucilia sericata (Diptera, Calliphoridae). Insect Biochemistry and Molecular Biology. 2011;41(1):70-75. Epub 2010 Sept 29. PMID: 20869440. https://doi.org/10.1016/j.ibmb.2010.09.006
  13. Chan DC, Fong DH, Leung JY, Patil N, Leung GK. Maggot debridement therapy in chronic wound care. Hong Kong Medical Journal. 2007;13(5):382-386. 
  14. Grassberger M, Sherman RA, Gileva OS, Kim CM, Mumcuoglu KY. Biotherapy—history, principles and practice. Dordrecht, Heidelberg, New York, London: Springer. 2013;37:38-39.  https://doi.org/10.1007/978-94-007-6585-6
  15. Sherman RA, Hall M, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annual Review of Entomology. 2000;45(1):55-81.  https://doi.org/10.1146/annurev.ento.45.1.55
  16. Robinson W. Ammonium bicarbonate secreted by surgical maggots stimulates healing in purulent wounds. The American Journal of Surgery. 1940;47(1):111-115.  https://doi.org/10.1016/S0002-9610(40)90125-8
  17. Altincicek B, Vilcinskas A. Septic injury‐inducible genes in medicinal maggots of the green blow fly Lucilia sericata. Insect Molecular Biology. 2009;18(1):119-125.  https://doi.org/10.1111/j.1365-2583.2008.00856.x
  18. Lerch K, Linde H-J, Lehn N, Grifka J. Bacteria ingestion by blowfly larvae: an in vitro study. Dermatology. 2003;207(4):362-326.  https://doi.org/10.1159/000074115
  19. Baumann A, Skaljac M, Lehmann R, Vilcinskas A, Franta Z. Urate Oxidase produced by Lucilia sericata medical maggots is localized in Malpighian tubes and facilitates allantoin production. Insect Biochemistry and Molecular Biology. 2017;83:44-53.  https://doi.org/10.1016/j.ibmb.2017.02.007
  20. Robinson W. Stimulation of healing in non-healing wounds: by allantoin occurring in maggot secretions and of wide biological distribution. JBJS. 1935;17(2):267-271. 
  21. Maleki-Ravasan N, Ahmadi N, Soroushzadeh Z, Raz AA, Zakeri S, Dinparast Djadid N. New insights into culturable and unculturable bacteria across the life history of medicinal maggots Lucilia sericata (Meigen) (Diptera: Calliphoridae). Frontiers in Microbiology. 2020;11:505.  https://doi.org/10.3389/fmicb.2020.00505
  22. Andersen AS, Sandvang D, Schnorr KM, Kruse T, Neve S, Joergensen B, et al. A novel approach to the antimicrobial activity of maggot debridement therapy. Journal of Antimicrobial Chemotherapy. 2010;65(8):1646-1654. https://doi.org/10.1093/jac/dkq165
  23. Steenvoorde P, Jacobi CE, Van Doorn L, Oskam J. Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome—a study on 101 patients with 117 wounds. The Annals of the Royal College of Surgeons of England. 2007;89(6):596-602.  https://doi.org/10.1308/003588407X205404
  24. Sherman RA. A new dressing design for use with maggot therapy. Plastic and Reconstructive Surgery. 1997;100(2):451-456.  https://doi.org/10.1097/00006534-199708000-00029
  25. Bazaliński D, Kózka M, Karnas M, Więch P. Effectiveness of chronic wound debridement with the use of larvae of Lucilia sericata. Journal of Clinical Medicine. 2019;8(11):1845. https://doi.org/10.3390/jcm8111845
  26. Sherman RA. Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century. Journal of Diabetes Science and Technology. 2009;3(2):336-344.  https://doi.org/10.1177/193229680900300215
  27. Wilasrusmee C, Marjareonrungrung M, Eamkong S, Attia J, Poprom N, Jirasisrithum S, et al. Maggot therapy for chronic ulcer: a retrospective cohort and a meta-analysis. Asian Journal of Surgery. 2014;37(3):138-147.  https://doi.org/10.1016/j.asjsur.2013.09.005
  28. Nuesch R, Rahm G, Rudin W, Steffen I, Frei R, Rufli T, Zimmerli W. Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae. Infection. 2002;30(5):306-309.  https://doi.org/10.1007/s15010-002-3067-0
  29. Gül E, Nurullazade Y, Kaya E. Larva Treatment From Past to Present in Chronic Wounds. International Journal of Traditional and Complementary Medicine Research. 2020;1(3):154-161.  https://dergipark.org.tr/en/pub/ijtcmr/issue/58250/827391
  30. Mumcuoglu K, Davidson E, Avidan A, Gilead L. Pain related to maggot debridement therapy. Journal of Wound Care. 2012;21(8):400-405.  https://doi.org/10.12968/jowc.2012.21.8.400
  31. Sherman RA, Shimoda KJ. Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection. Clinical Infectious Diseases. 2004;39(7):1067-1070. https://doi.org/10.1086/423806
  32. Ehteshaminia Y, Mohammadi H, Mahdavi SA, Rahimi MT. A Review on Maggot Therapy by Lucilia Sericata Larvae on Infectious Wounds. Tabari Biomedical Student Research Journal. 2020;2(3):28-37.  https://doi.org/10.18502/tbsrj.v2i3.4532
  33. Lipiński P, Trzciński R, Dziki Ł, Mik M. Phantom pain as an adverse effect after maggot (Lucilia sericata) debridement therapy: a case study. Journal of Wound Care. 2020;29(5):303-305.  https://doi.org/10.12968/jowc.2020.29.5.303
  34. Orkiszewski M. Maggots of Lucilia sericata in treatment of intractable wounds. Wiadomosci Lekarskie (Warsaw, Poland: 1960). 2007;60(7-8):381-385. 
  35. Choudhary V, Choudhary M, Pandey S, Chauhan VD, Hasnani J. Maggot debridement therapy as primary tool to treat chronic wound of animals. Veterinary World. 2016;9(4):403.  https://doi.org/10.14202/vetworld.2016.403-409
  36. Stadler F, Shaban RZ, Tatham P. Maggot debridement therapy in disaster medicine. Prehospital and Disaster Medicine. 2016;31(1): 79-84.  https://doi.org/10.1017/S1049023X15005427
  37. Mumcuoglu KY. Clinical applications for maggots in wound care. American Journal of Clinical Dermatology. 2001;2(4):219-227.  https://doi.org/10.2165/00128071-200102040-00003
  38. Mudge E, Price P, Neal W, Harding KG. A randomized controlled trial of larval therapy for the debridement of leg ulcers: results of a multicenter, randomized, controlled, open, observer blind, parallel group study. Wound Repair and Regeneration. 2014;22(1):43-51.  https://doi.org/10.1111/wrr.12127
  39. Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair and Regeneration. 2002;10(4):208-214.  https://doi.org/10.1046/j.1524-475x.2002.10403.x
  40. Aaron G, Nazni W, Lee H, Ariff M, Saranum M, Naicker A, et al. Maggot debridement Therapy with Lucilia cuprina: a comparison with convencional desbridement in diabetc foot ulcers. International Wound Journal. 2009;6:39-46.  https://doi.org/10.1111/j.1742-481X.2008.00564.x
  41. Tantawi TI, Williams KA, Villet MH. An accidental but safe and effective use of Lucilia cuprina (Diptera: Calliphoridae) in maggot debridement therapy in Alexandria, Egypt. Journal of Medical Entomology. 2010;47(3):491-494.  https://doi.org/10.1093/jmedent/47.3.491
  42. Cruz-Saavedra L, Díaz-Roa A, Gaona MA, Cruz ML, Ayala M, Cortés-Vecino JA, et al. The effect of Lucilia sericata- and Sarconesiopsis magellanica-derived larval therapy on Leishmania panamensis. Acta Tropica. 2016;164:280-289.  https://doi.org/10.1016/j.actatropica.2016.09.020
  43. Polat E, Kutlubay Z. Four cutaneous leishmaniosis case resistant to meglumine antimoniate treatment. Türkiye Parazitolojii Dergisi. 2014;38(3):177.  https://doi.org/10.5152/tpd.2014.3410
  44. Lin Y, Amin M, Donnelly AF, Amar S. Maggot debridement therapy of a leg wound from Kaposi’s sarcoma: A Case report. Journal of Global Oncology. 2015;1(2):92.  https://doi.org/10.1200/JGO.2015.001594
  45. Szczepanowski Z, Tukiendorf A, Krasowski G. Further data on wound healing rates after application of Lucilia sericata. The International Journal of Lower Extremity Wounds. 2021;20(1):47-54.  https://doi.org/10.1177/1534734619876840
  46. Yakovlev AY, Kruglikova A, Chernysh S. Calliphoridae flies in medical biotechnology. Entomological Review. 2019;99(3):292-301.  https://doi.org/10.1134/S0013873819030023
  47. Wolff H, Hansson C. Larval therapy—an effective method of ulcer debridement. Clinical and Experimental Dermatology: Clinical Dermatology. 2003;28(2):134-137.  https://doi.org/10.1046/j.1365-2230.2003.01226.x
  48. Kecici A, Polat E, Kutlubay Z. Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: an open‐label study. Clinical and Experimental Dermatology. 2021;46(5):834-841.  https://doi.org/10.1111/ced.14539
  49. Mirabzadeh A, Ladani M, Imani B, Rosen S, Sherman R. Maggot therapy for wound care in Iran: a case series of the first 28 patients. Journal of Wound Care. 2017;26(3):137-143.  https://doi.org/10.12968/jowc.2017.26.3.137
  50. Chaudhury M, Zhu J, Sagel A, Chen H, Skoda S. Volatiles from waste larval rearing media attract gravid screwworm flies (Diptera: Calliphoridae) to oviposit. Journal of Medical Entomology. 2014;51(3): 591-595.  https://doi.org/10.1603/ME13193
  51. Dethier VJ. Chemical insect attractants and repellents. LWW; 1948. https://www.worldcat.org/title/chemical-insect-attractants-and-repellents/oclc/1089984
  52. Erdmann G, Khalil S. Isolation and identification of two antibacterial agents produced by a strain of Proteus mirabilis isolated from larvae of the screwworm (Cochliomyia hominivorax) (Diptera: Calliphoridae). Journal of Medical Entomology. 1986;23(2):208-211.  https://doi.org/10.1093/jmedent/23.2.208
  53. Grabbe R, Turner J. Screwworm attractants: isolation and identification of organic compounds from bacterially inoculated and incubated blood. Folia Entomol Mex. 1973;25:120-121. 
  54. Richardson M. Studies on the biogenesis of some simple amines and quaternary ammonium compounds in higher plants. Isoamylamine and isobutylamine. Phytochemistry. 1966;5(1):23-30.  https://doi.org/10.1016/S0031-9422(00)85078-5
  55. Brodie B, Gries R, Martins A, VanLaerhoven S, Gries G. Bimodal cue complex signifies suitable oviposition sites to gravid females of the common green bottle fly. Entomologia Experimentalis et Applicata. 2014;153(2):114-127.  https://doi.org/10.1111/eea.12238
  56. Momeni Moghaddam M, Vatandoost J. Mouse skin wound healing using Lucilia sericata maggot extract. Cellular and Molecular Research (Iranian Journal of Biology). 2017;30(1):26-39.  https://cell.ijbio.ir/article_1200.html?lang=en
  57. König M, Vanscheidt W, Augustin M, Kapp H. Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. Journal of Wound Care. 2005;14(7):320-323.  https://doi.org/10.12968/jowc.2005.14.7.26813
  58. Telford G, Brown A, Seabra R, Horobin A, Rich A, English J, et al. Degradation of eschar from venous leg ulcers using a recombinant chymotrypsin from Lucilia sericata. British Journal of Dermatology. 2010;163(3):523-531.  https://doi.org/10.1111/j.1365-2133.2010.09854.x
  59. Telford G, Brown A, Kind A, English J, Pritchard D. Maggot chymotrypsin I from Lucilia sericata is resistant to endogenous wound protease inhibitors. British Journal of Dermatology. 2011;164(1):192-196.  https://doi.org/10.1111/j.1365-2133.2010.10081.x
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.